The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The mechanisms responsible for the evolution of steatosis towards NASH (non-alcoholic steatohepatitis) and fibrosis are not completely defined. In the present study we evaluated the role of CD4+ T-helper (Th) cells in this process. We analysed the infiltration of different subsets of CD4+ Th cells in C57BL/6 mice fed on a MCD (methionine choline-deficient) diet, which is a model reproducing all phases of human NASH progression. There was an increase in Th17 cells at the beginning of NASH development and at the NASH–fibrosis transition, whereas levels of Th22 cells peaked between the first and the second expansion of Th17 cells. An increase in the production of IL (interleukin)-6, TNFα (tumour necrosis factor α), TGFβ (transforming growth factor β) and CCL20 (CC chemokine ligand 20) accompanied the changes in Th17/Th22 cells. Livers of IL-17−/− mice were protected from NASH development and characterized by an extensive infiltration of Th22 cells. In vitro, IL-17 exacerbated the JNK (c-Jun N-terminal kinase)-dependent mouse hepatocyte lipotoxicity induced by palmitate. IL-22 prevented lipotoxicity through PI3K (phosphoinositide 3-kinase)-mediated inhibition of JNK, but did not play a protective role in the presence of IL-17, which up-regulated the PI3K/Akt inhibitor PTEN (phosphatase and tensin homologue deleted on chromosome 10). Consistently, livers of IL-17−/− mice fed on the MCD diet displayed decreased activation of JNK, reduced expression of PTEN and increased phosphorylation of Akt compared with livers of wild-type mice. Hepatic infiltration of Th17 cells is critical for NASH initiation and development of fibrosis in mice, and reflects an infiltration of Th22 cells. Th22 cells are protective in NASH, but only in the absence of IL-17. These data strongly support the potentiality of clinical applications of IL-17 inhibitors that can prevent NASH by both abolishing the lipotoxic action of IL-17 and allowing IL-22-mediated protection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD4 + T H 17 cells and CD8 + T cells have been shown to mediate NASH-associated liver fibrosis in both mice and humans (5-9).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [7]
In the citing paper
“Deficiency of this cytokine or its signalling components results in decreased hepatic accumulation of myeloid cells in models of NASH (7,52).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [7]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
The lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Liver fibrosis and repair: Immune regulation of wound healing in a solid organ
Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,143
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., & Sallusto, F. (2009) · Nature Immunology · doi:10.1038/ni.1767 · Cited by 1,079
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052
Bidirectional Relation Between Inflammation and Coagulation
Levi, M., van der Poll, T., & Büller, H. R. (2004) · Circulation · doi:10.1161/01.cir.0000131660.51520.9a · Cited by 941
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M., & Flavell, R. A. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.023 · Cited by 628
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Malhi, H., & Gores, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091980 · Cited by 538
IL‐22, not simply a Th17 cytokine
Rutz, S., Eidenschenk, C., & Ouyang, W. (2013) · Immunological Reviews · doi:10.1111/imr.12027 · Cited by 435
Ki, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B. (2010) · Hepatology · doi:10.1002/hep.23837 · Cited by 434
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G., & Tiribelli, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.003 · Cited by 425
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Sonnenberg, G. F., Nair, M. G., Kirn, T. J., Zaph, C., Fouser, L. A., & Artis, D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092054 · Cited by 380
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Shimada, M., Hashimoto, E., Taniai, M., Hasegawa, K., Okuda, H., Hayashi, N., Takasaki, K., & Ludwig, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00099-5 · Cited by 356
Platelets: at the nexus of antimicrobial defence
Yeaman, M. R. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3269 · Cited by 352
Animal models of NASH: Getting both pathology and metabolic context right
Larter, C. Z., & Yeh, M. M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05543.x · Cited by 337
Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation
COX, D., KERRIGAN, S. W., & WATSON, S. P. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04264.x · Cited by 315
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia
Aras, O., Shet, A., Bach, R. R., Hysjulien, J. L., Slungaard, A., Hebbel, R. P., Escolar, G., Jilma, B., & Key, N. S. (2004) · Blood · doi:10.1182/blood-2003-03-0713 · Cited by 297
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294
Hundelshausen, P. V., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 271
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., & Albano, E. (2014) · Hepatology · doi:10.1002/hep.26749 · Cited by 270
Role of IL-17 and Th17 Cells in Liver Diseases
Hammerich, L., Heymann, F., & Tacke, F. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/345803 · Cited by 261
de Jonge, E., Dekkers, P. E. P., Creasey, A. A., Hack, C. E., Paulson, S. K., Karim, A., Kesecioglu, J., Levi, M., van Deventer, S. J. H., & van der Poll, T. (2000) · Blood · doi:10.1182/blood.v95.4.1124.002k20_1124_1129 · Cited by 259
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
Harley, I. T. W., Stankiewicz, T. E., Giles, D. A., Softic, S., Flick, L. M., Cappelletti, M., Sheridan, R., Xanthakos, S. A., Steinbrecher, K. A., Sartor, B. R., et al. (2014) · Hepatology · doi:10.1002/hep.26746 · Cited by 250
The role of platelets in sepsis
van ’t Veer, C., Poll, T. V. D., & de Stoppelaar, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-02-0126 · Cited by 247
Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., Burt, A. D., & Day, C. P. (2005) · Gut · doi:10.1136/gut.2004.057968 · Cited by 219
A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury
Ma, X., Hua, J., Mohamood, A. R., Hamad, A. R. A., Ravi, R., & Li, Z. (2007) · Hepatology · doi:10.1002/hep.21823 · Cited by 198
Regulation of Adhesion Molecules during Human Endotoxemia: No Acute Effects of Aspirin
JILMA, B., BLANN, A., PERNERSTORFER, T., STOHLAWETZ, P., EICHLER, H.-G., VONDROVEC, B., AMIRAL, J., RICHTER, V., & WAGNER, O. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.3.9805087 · Cited by 197
Zhao, J., Zhang, Z., Luan, Y., Zou, Z., Sun, Y., Li, Y., Jin, L., Zhou, C., Fu, J., Gao, B., et al. (2014) · Hepatology · doi:10.1002/hep.26916 · Cited by 174
SPIEL, A. O., MAYR, F. B., FIRBAS, C., QUEHENBERGER, P., & JILMA, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01715.x · Cited by 164
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22
Yang, L., Zhang, Y., Wang, L., Fan, F., Zhu, L., Li, Z., Ruan, X., Huang, H., Wang, Z., Huang, Z., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.004 · Cited by 159
Cellular sources of tissue factor in endotoxemia and sepsis
Pawliński, R., & Mackman, N. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.042 · Cited by 142
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
Chavez-Tapia, N. C., Rosso, N., & Tiribelli, C. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-20 · Cited by 137
Prehospitalization Antiplatelet Therapy Is Associated With a Reduced Incidence of Acute Lung Injury
Erlich, J. M., Talmor, D. S., Cartin‐Ceba, R., Gajic, O., & Kor, D. J. (2010) · CHEST Journal · doi:10.1378/chest.10-0891 · Cited by 136
Heparin Blunts Endotoxin-Induced Coagulation Activation
Pernerstorfer, T., Hollenstein, U., Hansen, J.-B., Knechtelsdorfer, M., Stohlawetz, P. J., Graninger, W. B., Eichler, H. G., Speiser, W., & Jilma, B. (1999) · Circulation · doi:10.1161/01.cir.100.25.2485 · Cited by 133
Regulation and pro‐inflammatory function of interleukin‐17 family cytokines
Dong, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00709.x · Cited by 125
The coagulation system and its function in early immune defense
van der Poll, T., & Herwald, H. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0053 · Cited by 124
Use of antiplatelet agents in sepsis: A glimpse into the future
Akinosoglou, K., & Alexopoulos, D. K. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.002 · Cited by 124
Siller-Matula, J. M., Krumphuber, J., & Jilma, B. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00555.x · Cited by 116
[Possibilities and limitations of thrombelastometry/-graphy].
Lang�, T., & von Depka, M. (2006) · PubMed · Cited by 108
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit*
Winning, J., Neumann, J. H. L., Kohl, M., Claus, R. A., Reinhart, K., Bauer, M. W., & Lösche, W. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b4275c · Cited by 107
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Rolla, S., Bardina, V., Mercanti, S. F. D., Quaglino, P., Palma, R. D., Gned, D., Brusa, D., Durelli, L., Novelli, F., & Clerico, M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0813-463rr · Cited by 101
Self-citationOxidative stress parameters in paediatric non-alcoholic fatty liver disease
Nobili (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000487 · Cited by 92
Effects of Endotoxemia on Thrombopoiesis in Men
Stohlawetz, P., Folman, C. C., von dem Borne, A. E. G. K., Pernerstorfer, T., Eichler, H.-G., Panzer, S., & Jilma, B. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614534 · Cited by 91
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice
Maina, V., Sutti, S., Locatelli, I., Vidali, M., Mombello, C., Bozzola, C., & Albano, E. (2011) · Clinical Science · doi:10.1042/cs20110366 · Cited by 88
Self-citationPrognosis in nonalcoholic steatohepatitis
Propst, A., Propst, T., Judmaier, G., & Vogel, W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90724-6 · Cited by 86
Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia
Derhaschnig, U., Bergmair, D., Marsik, C. L., Kanter‐Schlifke, I., Wijdenes, J., & Jilma, B. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000126265.08175.be · Cited by 79
Tai, W.-T., Shiau, C.-W., Chen, P.-J., Chu, P.-Y., Huang, H.-P., Liu, C.-Y., Huang, J.-W., & Chen, K.-F. (2014) · Hepatology · doi:10.1002/hep.26640 · Cited by 75
Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
Charlton, M. (2008) · Hepatology · doi:10.1002/hep.22246 · Cited by 71
Hagiwara, S., Iwasaka, H., Hasegawa, A., Oyama, M., Imatomi, R., Uchida, T., & Noguchi, T. (2010) · Shock · doi:10.1097/shk.0b013e3181f48987 · Cited by 71
Protective and Pathological Properties of IL-22 in Liver Disease
Cobleigh, M. A., & Robek, M. D. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.043 · Cited by 70
Endotoxin-Induced Activation of the Coagulation Cascade in Humans
Pernerstorfer, T., Stohlawetz, P. J., Hollenstein, U., Dzirlo, L., Eichler, H. G., Kapiotis, S., Jilma, B., & Speiser, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2517 · Cited by 68
Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans
Jilma, B., Marsik, C. L., Mayr, F., Graninger, M., Taylor, F. B., Ribel, M. C., Erhardtsen, E., Handler, S., & Eichler, H. G. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127740 · Cited by 68
Sparna, T., Rétey, J., Schmich, K., Albrecht, U., Naumann, K., Gretz, N., Fischer, H., Bode, J. G., & Merfort, I. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-226 · Cited by 66
PERNERSTORFER, T., SCHMID, R., BIEGLMAYER, C., EICHLER, H., KAPIOTIS, S., & JILMA, B. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70053-6 · Cited by 64
The Role of P2Y12 Receptor and Activated Platelets During Inflammation
Liverani, E., Kilpatrick, L. E., Tsygankov, A. Y., & Kunapuli, S. P. (2014) · Current Drug Targets · doi:10.2174/1389450115666140519162133 · Cited by 61
Fibrogenic signalling in hepatic stellate cells
Mann, D. A., & Marra, F. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.005 · Cited by 58
Human Endotoxin Administration as an Experimental Model in Drug Development
Suffredini, A. F., & Noveck, R. J. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.146 · Cited by 57
Jilma, B., Voltmann, J., Albinni, S., Stohlawetz, P. J., Schwarzinger, I., Gleiter, C. H., Rauch, A., Eichler, H. G., & Wagner, O. F. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90052-7 · Cited by 56
Zakai, N. A., CALLAS, P. W., Repp, A. B., & Cushman, M. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12147 · Cited by 56
Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation
Kälsch, T., Elmas, E., Nguyen, X. D., Suvajac, N., Klüter, H., Borggrefe, M. M., & Dempfle, C. ‐. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0667-y · Cited by 53
Totani, L., Dell’Elba, G., Martelli, N., Santo, A. D., Piccoli, A. L., Jr., Amore, C., & Evangelista, V. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-12-0867 · Cited by 53
Alchera, E., Tacchini, L., Imarisio, C., Ponte, C. D., Ponti, C. D., Gammella, E., Cairo, G., Albano, E., & Carini, R. (2008) · Hepatology · doi:10.1002/hep.22249 · Cited by 50
Self-citationImarisio, C., Alchera, E., Sutti, S., Valente, G., Boccafoschi, F., Albano, E., & Carini, R. (2012) · Clinical Science · doi:10.1042/cs20110504 · Cited by 49
Self-citationEffects of estradiol on circulating P-selectin
Jilma, B., Hildebrandt, J., Kapiotis, S., Wagner, O. F., Kitzweger, E., Müllner, C., Monitzer, B., Krejcy, K., & Eichler, H. G. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.6.8964876 · Cited by 48
Baker, J. V., Hullsiek, K. H., Bradford, R. L., Prosser, R., Tracy, R. P., & Key, N. S. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182910121 · Cited by 45
Vaidyula, V. R., Bagga, S., Jalagadugula, G. S., Gaughan, J. P., Wilhite, D. B., Comerota, A. J., & Rao, A. K. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-08-0451 · Cited by 44
Derhaschnig, U., Schweeger-Exeli, I., Marsik, C. L., Cardona, F., Minuz, P., & Jilma, B. (2010) · Platelets · doi:10.3109/09537101003735572 · Cited by 39
Prasugrel Metabolites Inhibit Neutrophil Functions
Liverani, E., Rico, M. C., Garcia, A. E., Kilpatrick, L. E., & Kunapuli, S. P. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195883 · Cited by 38
Reiter, R. A., Derhaschnig, U., Spiel, A. O., Keen, P., Cardona, F., Mayr, F., & Jilma, B. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0245 · Cited by 36
Racial differences in endotoxin-induced tissue factor-triggered coagulation
Mayr, F., Spiel, A. O., Leitner, J. M., Firbas, C., Jilma‐Stohlawetz, P., Chang, J.-Y., Key, N. S., & Jilma, B. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03307.x · Cited by 34
Jakubowski, J. A., Zhou, C., Jurčević, S., Winters, K. J., Lachno, D. R., Frelinger, A. L., Gupta, N., Howard, J., Payne, C. D., & Mant, T. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.12.008 · Cited by 33
Coagulation interventions in experimental human endotoxemia
Mayr, F., & Jilma, B. (2006) · Translational research · doi:10.1016/j.trsl.2006.08.002 · Cited by 33
Derhaschnig, U., Pachinger, C., & Jilma, B. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.11.003 · Cited by 29
Derhaschnig, U., Pachinger, C., Schweeger-Exeli, I., Marsik, C. L., & Jilma, B. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0233 · Cited by 25
Cited by
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Zhou, D., Pan, Q., Shen, F., Cao, H.-X., Ding, W.-J., Chen, Y.-W., & Fan, J.-G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01751-y · Cited by 421
Adaptive immunity: an emerging player in the progression of NAFLD
Sutti, S., & Albano, E. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0210-2 · Cited by 374
Ruiz de Morales, J. M. G., Puig, L., Daudén, E., Cañete, J. D., Pablos, J. L., Martín, A. O., Juanatey, C. G., Adán, A., Montalbán, X., Borruel, N., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102429 · Cited by 338
T Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 330
Metadata
- Authors
- Rolla, S., Alchera, E., Imarisio, C., Bardina, V., Valente, G., Cappello, P., Mombello, C., Follenzi, A., Novelli, F., & Carini, R.
- Affiliations
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- ORCID
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2015-12-17
- Volume
- 130
- Issue
- 3
- Pages
- 193-203
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2196060005
- Cited by
- 158
- References
- 80
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 15 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 16 · 2019: 12 · 2018: 9 · 2017: 9 · 2016: 6
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- nonalcoholic steatohepatitis, IL-17, IL-22, Th17 cells, Th22 cells, CD4+ T helper cells, liver fibrosis, steatosis, methionine-choline-deficient diet, palmitate, JNK signaling, PI3K/Akt signaling, PTEN, CCL20, interleukin-6, TNF-α, TGF-beta, IL-17 inhibitors
- MeSH terms
- Interleukin-22, Animals, Disease Models, Animal, T-Lymphocytes, Helper-Inducer, Interleukins, Liver, Male, Mice, Inbred C57BL, Interleukin-17, T-Lymphocytes, Regulatory, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.